Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States

Figure 1 Flowchart of study cohorts identification. We identified all adult (age ≥ 18) first-time solitary kidney transplantation recipients from an ABO-compatible deceased donor between January 1994 and March 2019 in the United States Patients with missing or uncertain hepatitis C virus (HCV)-antibody status in the donor or recipient were excluded. Patients were allocated into four groups according to HCV infection in the donor (D+) or recipient (R+): D-R-, D+R-, D-R+, and D+R+. KP: Kidney-pancreas; HCV: Hepatitis C virus; ABO-MAT: ABO-blood type match.